115 related articles for article (PubMed ID: 20973208)
21. The lady with raised prostate specific antigen: do we need to worry?
Das S; Paul R; De U; Mukhopadhyay M
Asian Pac J Cancer Prev; 2011; 12(8):2051-3. PubMed ID: 22292649
[TBL] [Abstract][Full Text] [Related]
22. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.
Oesterling JE; Jacobsen SJ; Chute CG; Guess HA; Girman CJ; Panser LA; Lieber MM
JAMA; 1993 Aug; 270(7):860-4. PubMed ID: 7688054
[TBL] [Abstract][Full Text] [Related]
23. Discrimination of breast cancer by measuring prostate-specific antigen levels in women's serum.
Chang YF; Hung SH; Lee YJ; Chen RC; Su LC; Lai CS; Chou C
Anal Chem; 2011 Jul; 83(13):5324-8. PubMed ID: 21591802
[TBL] [Abstract][Full Text] [Related]
24. Detection of nonprostatic PSA in serum and nonserum samples from women.
Filella X; Molina R; Alcover J; Carretero P; Ballesta AM
Int J Cancer; 1996 Nov; 68(4):424-7. PubMed ID: 8945610
[TBL] [Abstract][Full Text] [Related]
25. [Status of PSA determination for early detection of prostate carcinoma].
Hammerer P; Huland H
Versicherungsmedizin; 1995 Jun; 47(3):83-6. PubMed ID: 7541925
[TBL] [Abstract][Full Text] [Related]
26. Super-sensitive prostate-specific antigen (PSA) in serum of women with benign breast disease or breast cancer.
Hautmann S; Huland E; Grupp C; Haese A; Huland H
Anticancer Res; 2000; 20(3B):2151-4. PubMed ID: 10928169
[TBL] [Abstract][Full Text] [Related]
27. Prostatic specific antigen (PSA).
Alberti C
Minerva Urol Nefrol; 1993 Jun; 45(2):83-4. PubMed ID: 7694380
[No Abstract] [Full Text] [Related]
28. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. I. PSA, PSA density, and predicted PSA].
Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Allona Almagro A; Gomez dos Santos V
Arch Esp Urol; 1997 May; 50(4):333-8. PubMed ID: 9313041
[TBL] [Abstract][Full Text] [Related]
29. Prostate-specific antigen (PSA/hK3): a further player in the field of breast cancer diagnostics?
Mannello F; Gazzanelli G
Breast Cancer Res; 2001; 3(4):238-43. PubMed ID: 11434875
[TBL] [Abstract][Full Text] [Related]
30. [Significance and limitations of f/tPSA in differential diagnosis of prostate cancer with tPSA levels between 4 and 10 ng/ml].
Chen ZD; Wei SM; Cai SL
Zhonghua Wai Ke Za Zhi; 2004 May; 42(10):593-5. PubMed ID: 15265401
[TBL] [Abstract][Full Text] [Related]
31. [Value of PSA density determination in prostate carcinoma].
Manseck A; Benusch T; Wirth M
Urologe A; 1997 Jul; 36(4):323-6. PubMed ID: 9340897
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of free-to-total prostate specific antigen (F/T PSA), prostate specific antigen density (PSAD) and (F/T)/PSAD sensitivity on reduction of unnecessary prostate biopsies for patients with PSA in gray zone.
Milkovic B; Dzamic Z; Pejcic T; Kajmakovic B; Nikolic D; Cirovic D; Knezevic T; Dzamic D; Hadzi-Djokic J
Ann Ital Chir; 2014; 85(5):448-53. PubMed ID: 25599711
[TBL] [Abstract][Full Text] [Related]
33. Incorporating the time dimension in receiver operating characteristic curves: a case study of prostate cancer.
Etzioni R; Pepe M; Longton G; Hu C; Goodman G
Med Decis Making; 1999; 19(3):242-51. PubMed ID: 10424831
[TBL] [Abstract][Full Text] [Related]
34. Influence of serum prostate-specific antigen (PSA) level, prostate volume, and PSA density on prostate cancer detection with contrast-enhanced sonography using contrast-tuned imaging technology.
Xie SW; Li HL; Du J; Xia JG; Guo YF; Xin M; Li FH
J Ultrasound Med; 2013 May; 32(5):741-8. PubMed ID: 23620314
[TBL] [Abstract][Full Text] [Related]
35. [MSA--a new sensitive tumor marker in breast carcinoma].
Zahm DM; Greinke C; Nöschel H
Zentralbl Gynakol; 1996; 118(12):659-64. PubMed ID: 9082702
[TBL] [Abstract][Full Text] [Related]
36. [Prostate-specific antigen as a tumor marker of prostate carcinoma].
Wymenga LF; Mensink HJ
Ned Tijdschr Geneeskd; 1999 Aug; 143(34):1733-8. PubMed ID: 10494319
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of serum CA-15.3 in the management of benign breast lesion.
Mondal HP; Roy H; Mondal P; Saha M; Basu N
J Indian Med Assoc; 2012 Apr; 110(4):242-4. PubMed ID: 23025224
[TBL] [Abstract][Full Text] [Related]
38. [Tumor markers in diagnosis of breast cancer].
Bartel U
Z Arztl Fortbild (Jena); 1991 Oct; 85(20):1015-21. PubMed ID: 1776283
[No Abstract] [Full Text] [Related]
39. [Pregnancy protein-1 in the serum of patients with diseases of the breast].
Strache RR; Briese V; Szabo DG; Than GN; Kunze M; Richter D
Zentralbl Gynakol; 1987; 109(5):274-9. PubMed ID: 3035827
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of prostate specific antigen for early stage prostate cancer detection.
Imai K; Ichinose Y; Kubota Y; Yamanaka H; Sato J; Saitoh M; Watanabe H; Ohe H
Jpn J Clin Oncol; 1994 Jun; 24(3):160-5. PubMed ID: 7516445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
